Measurement of plasma ibuprofen by gas chromatography-mass spectrometry

Journal of Clinical Laboratory Analysis

Volumn 11, Issue 6, 1997, Pages 336-339

  Way, Barbara A ^a   Wilhite, Timothy R ^b   Smith, Carl H ^a   Landt, Michael ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Anti inflammatory agents; Cystic fibrosis; GC MS; Ibuprofen; NSAIDS

Indexed keywords

FLURBIPROFEN; IBUPROFEN;

ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG BLOOD LEVEL; DRUG MEGADOSE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTIC FIBROSIS; DRUG MONITORING; FENOPROFEN; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IBUPROFEN; KETOPROFEN; NAPROXEN; SENSITIVITY AND SPECIFICITY;

EID: 0030776207     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1997)11:6<336::AID-JCLA4>3.0.CO;2-3     Document Type: Article

References (15)

1. Konstan MW, Hoppel CL, Chai B, Davis PB: Ibuprofen in children with cystic fibrosis: Pharmacokinetics and adverse effects. J Pediatr 118:956-964, 1991.
2. Konstan MW, Vargo KM, Davis PB: Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection: Implications for antiinflammatory therapy in cystic fibrosis. Am Rev Respir Dis 141:186-192, 1990.
3. Okrent DG, Lichtenstein AK, Ganz T: Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells. Am Rev Respir Dis 141:179-185, 1990.
4. Colton HR: Airway inflammation in cystic fibrosis. N Engl J Med 332:886-887, 1995.
5. Thompson AB, Smits WL, Pick RB: Immunomodulatory therapies for cystic fibrosis. Semin Resp Infect 7:218-226, 1992.
6. Maderazo EG, Breaux SP, Woronick CL: Inhibition of human polymorphonuclear leukocyte cell responses by ibuprofen. J Pharm Sci 73:1403-1406, 1984.
7. Konstan MW, Byard PJ, Hoppel CL, Davis PB: Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 332:848-854, 1995.
8. Minkler PE, Hoppel CL: Determination of ibuprofen in human plasma by high-performance liquid chromatography. J Chromatogr 428:388-394, 1988.
9. Whitlam JB, Vine JH: Quantitation of ibuprofen in biological fluids by gas chromatography-mass spectrometry. J Chromatogr 181:463-468. 1980.
10. Jack DS. Rumble RH. Davies NW: Enantiospecific gas chromaiographic-mass spectrometric procedure for the determination of ketoprofen and ibuprofen in synovial fluid and plasma: application to protein binding studies J Chromatogr 584:187-197, 1992.
11. Aravind MK, Miceli JN, Kauffman RE: Determination of ibuprofen by high-performance liquid chromatography. J Chromatogr 308:350-353, 1984
12. Albert KS, Raabe A, Garry M, Antal EJ, Gillespie WR: Determination of ibuprofen in capillary and venous plasma by high-performance liquid chromatography with ultraviolet detection. J Pharm Sci 73:1487-1489, 1984.
13. Hoffman DJ: Rapid GLC determination of ibuprofen in serum. J Pharm Sci 66:749-750, 1977.
14. Kaiser DG, VanGiessen GJ: GLC determination of ibuprofen [(±)-2-(p-isobutylphenyl)propionic acid] in plasma. J Pharm Sci 63:219-221, 1974.
15. Heikkinen L: Silica capillary gas chromatographic determination of ibuprofen in serum. J Chromatogr 307:206-209, 1984.